Monday, May 2, 2022

Bipartisan group calls on House leadership to not tie aid to Ukraine to COVID-19-related funding

A bipartisan group of U.S. military veterans in Congress has called on U.S. House Speaker Nancy Pelosi and Minority Leader Kevin McCarthy to not tie additional aid to Ukraine to COVID-19-relief funding.

President Joe Biden asked Congress to authorize an additional $33 billion in funding for Ukraine in a supplemental bill, which also includes another $10 billion in additional COVID-19 relief money.

The bipartisan group says it isn't "In the best interests of U.S. national security to link further foreign and military aid to Ukraine to unrelated COVID-19 supplemental funding legislation." The letter was signed by U.S. Reps.

Comprehensive aid would include "Military supplies, economic assistance, and traditional foreign aid," they argue, "Intended to demonstrate our sustained commitment to Ukraine, rather than funding assistance in a piecemeal approach every several weeks." The additional coronavirus relief funding was necessary, Biden said, "To avoid needless deaths in the United States and around the world," saying it was "Much needed, life-saving COVID funding." Pelosi told reporters Thursday she supported funding for both in one bill.

"We have emergencies here. We need to have the COVID money, and we need - time is of the essence because we need the Ukraine money. We need the COVID money. So I would hope that we can do that. That's - this is called legislation and we're legislating and we'll have to come to terms on how we do that." The package includes $20 billion in military assistance, $8.5 billion in economic assistance, and $3 billion in humanitarian aid.

On March 11, the president approved a $13.6 billion aid package to Ukraine to send weapons and U.S. troops to Europe.

On March 16, the White House announced an additional $800 million in security assistance to Ukraine.

https://justthenews.com/nation/states/center-square/bipartisan-group-calls-house-leadership-not-tie-aid-ukraine-covid-19 

No comments:

Post a Comment